{"product_id":"ss-31","title":"SS-31","description":"\u003cp\u003eMitochondria-targeted tetrapeptide (Forzinity). FDA-approved September 2025 for Barth syndrome—first FDA-approved mitochondria-targeted therapeutic.\u003c\/p\u003e","brand":"Newtide","offers":[{"title":"10mg","offer_id":55923178701122,"sku":null,"price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1008\/9490\/0546\/files\/SS3110mgnbg.png?v=1786740228","url":"https:\/\/newtide.market\/products\/ss-31","provider":"Newtide","version":"1.0","type":"link"}